Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

University of Toronto at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

University of Toronto brings 12 presentations to ASH 2026 in New Orleans. Its program spans thalassemia, sickle cell disease, lymphoma and transfusion medicine. It includes a session on long-term thalassemia care and a hematology education curriculum project.

OrganizationASH 2026 Attendance
University of Toronto
Toronto, Canada
Universities & research institutes
Public research university in Toronto, Ontario, affiliated with the city's major teaching hospitals.
Session
Sat Dec 12
4:00pm–5:15pm
Longer Lives, New Challenges: Managing Thalassemia in 2026
Challenges as people with thalassemia live longer, including pregnancy, cheaper and safer gene therapy, and aging with the non-transfusion-dependent form.
Red cells
Talk
Sat Dec 12
4:00pm–5:15pm
Pregnancy in Transfusion-Dependent and Non-Transfusion Dependent Thalassemia (TDT and NTDT)
Pregnancy risks for women with thalassemia, whether or not they need regular transfusions, and team-based care from pre-conception counseling to after delivery.
Red cells

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Toronto

Tell us what you sell and we’ll find the people at University of Toronto most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction